HIV-1_NN
reactivation_NN
in_IN
resting_VBG
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
of_IN
infected_JJ
adults_NNS
upon_IN
in_FW
vitro_FW
CD4_NN
cross-linking_NN
by_IN
ligands_NNS
of_IN
the_DT
CDR2-loop_NN
in_IN
extracellular_JJ
domain_NN
1_CD
._.

HIV-1_NN
infects_VBZ
resting_VBG
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
-LRB-_-LRB-
PBMCs_NNS
-RRB-_-RRB-
but_CC
remains_VBZ
inactive_JJ
state_NN
until_IN
subsequent_JJ
cell_NN
activation_NN
._.

We_PRP
have_VBP
demonstrated_VBN
that_IN
the_DT
cross-linking_NN
of_IN
cell_NN
surface_NN
CD4_NN
by_IN
gp120-anti-gp120_NN
immune_JJ
complexes_NNS
or_CC
heat-inactivated_JJ
HIV-1_NN
-LRB-_-LRB-
iHIV-1_NN
-RRB-_-RRB-
is_VBZ
sufficient_JJ
to_TO
trigger_VB
activation_NN
signals_NNS
leading_VBG
to_TO
virus_NN
reactivation_NN
-LRB-_-LRB-
9_CD
-RRB-_-RRB-
._.

In_IN
this_DT
study_NN
,_,
we_PRP
demonstrate_VBP
that_IN
NF-kappaB_NN
nuclear_JJ
translocation_NN
and_CC
stimulation_NN
of_IN
virus_NN
production_NN
by_IN
iHIV-1_NN
were_VBD
strictly_RB
linked_VBN
to_TO
the_DT
concentrations_NNS
of_IN
viral_JJ
proteins_NNS
used_VBN
as_IN
exogenous_JJ
stimuli_NNS
._.

Moreover_RB
,_,
we_PRP
further_RB
investigated_VBD
the_DT
physiologic_JJ
relevance_NN
of_IN
these_DT
observations_NNS
._.

When_WRB
submitted_VBN
to_TO
an_DT
in_FW
vitro_FW
CD4_NN
cross-linking_NN
by_IN
iHIV-1_NN
,_,
PBMCs_NNS
from_IN
HIV-1-infected_JJ
patients_NNS
were_VBD
found_VBN
to_TO
produce_VB
virus_NN
._.

This_DT
viral_JJ
reactivation_NN
was_VBD
associated_VBN
with_IN
increased_VBN
NF-kappaB_NN
nuclear_JJ
translocation_NN
in_IN
patients_NNS
'_POS
PBMCs_NNS
._.

Additionally_RB
,_,
virus_NN
reactivation_NN
in_IN
resting_VBG
PBMCs_NNS
infected_VBN
in_FW
vitro_FW
with_IN
HIV-1_NN
was_VBD
found_VBN
to_TO
be_VB
specifically_RB
induced_VBN
by_IN
ligands_NNS
of_IN
the_DT
CDR2-loop_NN
in_IN
domain_NN
1_CD
-LRB-_-LRB-
D1_NN
-RRB-_-RRB-
of_IN
CD4_NN
-LRB-_-LRB-
virus_NN
envelope_NN
and_CC
anti-CD4_JJ
monoclonal_JJ
antibodies_NNS
-RRB-_-RRB-
._.

In_IN
contrast_NN
,_,
virus_NN
reactivation_NN
was_VBD
not_RB
observed_VBN
following_VBG
CD4_NN
oligomerization_NN
by_IN
antibodies_NNS
that_WDT
bind_VBP
other_JJ
epitopes_NNS
in_IN
D1_NN
,_,
including_VBG
the_DT
D1\/CDR3-loop_NN
._.

Finally_RB
,_,
soluble_JJ
CD4_NN
-LRB-_-LRB-
sCD4_NN
-RRB-_-RRB-
prevented_VBD
virus_NN
reactivation_NN
by_IN
D1\/CDR2-loop_NN
ligands_NNS
._.

Our_PRP$
results_NNS
indicate_VBP
that_IN
the_DT
signaling_VBG
events_NNS
initiated_VBN
in_IN
PBMCs_NNS
by_IN
oligomerization_NN
of_IN
CD4_NN
at_IN
the_DT
D1\/CDR2-loop_NN
can_MD
trigger_VB
HIV-1_NN
upregulation_NN
in_IN
infected_JJ
individuals_NNS
._.

